MapLight Therapeutics, Inc. Common Stock (MPLT) is a publicly traded the market company. As of November 9, 2026, MPLT trades at $7.29 with a market cap of $385.14M and a P/E ratio of -0.51. MPLT moved +5.34% today. Year to date, MPLT is -56.56%; over the trailing twelve months it is -53.33%. Its 52-week range spans $6.06 to $40.43. Analyst consensus is buy with an average price target of $26.80. Rallies surfaces MPLT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for MPLT, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $7.29 |
| Market Cap | $385.14M |
| P/E Ratio | -0.51 |
| EPS | $-18.56 |
| Dividend Yield | 0.00% |
| 52-Week High | $40.43 |
| 52-Week Low | $6.06 |
| Volume | 380.92K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-161.15M |
| Gross Margin | 0.00% |
6 analysts cover MPLT: 0 strong buy, 3 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $26.80.